AWM
GMAB icon

Atticus Wealth Management’s Genmab GMAB Stock Holding History

Atticus Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,094
Closed -$44K – 351
2020
Q4 		$44K Hold
1,094
– – 0.02% 221
2020
Q3 		$40K Sell
1,094
-3
-0.3% -$108 0.02% 190
2020
Q2 		$37K Buy
+1,097
New +$29.9K 0.02% 185
2020
Q1 		– Sell
-9
Closed – – 357
2019
Q4 		$0 Buy
+9
New +$196 ﹤0.01% 394

Other funds holding GMAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Atticus Wealth Management's GMAB Position: Q1 2021 in Review

Atticus Wealth Management sold out of Genmab (GMAB) in Q1 2021, closing a stake of 1,094 shares — an estimated $44K sold.

Atticus Wealth Management first reported a position in GMAB in Q4 2019 and held it in 4 quarters. The position peaked at $44K in Q4 2020. 209 funds tracked by Wall St. Rank hold GMAB as of Q1 2021.

  • Atticus Wealth Management reported no remaining Genmab position as of Q1 2021 after selling out during the quarter.
  • Atticus Wealth Management sold 1,094 Genmab shares in Q1 2021, an estimated $44K.
  • Atticus Wealth Management first reported a position in Genmab in Q4 2019 and held it in 4 quarters.
  • Atticus Wealth Management's Genmab position peaked at $44K in Q4 2020.
  • 209 funds tracked by Wall St. Rank held Genmab as of Q1 2021.

Based on Atticus Wealth Management's 13F filing for Q1 2021, filed 15 Apr 2021.